Org 3770 VS amitriptyline in the continuation treatment of depression: A placebo controlled trial

European Journal of Psychiatry

Volumn 10, Issue 1, 1996, Pages 5-15

  Bremner, James D ^a   Smith, Ward T ^b  

^a Bremner Research Institute   (United States)

^b Pac Northwest Clin Research Center   (United States)

Author keywords

continuation treatment; major depression; Org 3770

Indexed keywords

AMITRIPTYLINE; MIRTAZAPINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; SIDE EFFECT;

EID: 0029984657     PISSN: 02136163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders - third edition. American Psychiatric Association, Washington DC, 1980.
2. AMERICAN PSYCHIATRIC ASSOCIATION. Practice guidelines for major depressive disorder in adults, American Journal of Psychiatry 150: (4, Suppl.) 1-26, 1993.
3. BECH P., ALLERUP P., REISBY N., GRAM LF. Assessment of symptom change from improvement curves on the Hamilton Depression Scale in trials with antidepressants, Psychopharmacology 84: 276-281; 1984.
4. BREMNER JD. A double blind comparison of Org 3770, amitriptyline and placebo in major depression, submitted.
5. CINP TASK FORCE. Impact of neurophamracology in the 1990's - strategies for the therapy of depressive illness. European Neuropsychopharmacology 3: 153-156; 1993.
6. CLAGHORN JL. A double blind, placebo controlled study of Org 3770 in depressed outpatients, Journal of Affective Disorders, in press.
7. CLEMENT HH, GEMSA D., WESEMAN W. The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vitro voltametry. European Journal of Pharmacology 217: 43-48; 1992.
8. DANISH UNIVERSITY ANTIDEPRESSANT GROUP (DUAG). Citalopram: Clinical effect profile in comparison with clomipramine: A controlled multicenter study, Psychopharmacology 90: 131-138, 1986
9. DE BOER, T. NEFKENS F VAN HELVOIRT A The alpha2-.adrenoreceptor antagonist Org 3770 enhances serotonin transmission in vivo, European Journal of Pharmacology 253: R5-R6, 1994.
10. DOOGAN DP, CAILLARD V. Sertraline in the prevention of depression, British Journal of Psychiatry 160: 217-222, 1992.
11. FRANK E., KUPFER DJ., PEREL JM., CORNES C., JARETT DB., MALLINGER AG, THASE ME., McEACHRAN AB., GROCOCHINSKI VJ. Threee-year outcomes for maintenance therapies in recurrent depression, Archives of General Psychiatry 47: 1093-1097, 1990.
12. FRANK E., KUPFER DJ, PEREL JM., CORNES C., MALLINGER AG., THASE ME, McEACHRAN AB, GROCHOCINSKI VJ. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression Journal of Affective Disorders 27: 139-145; 1993.
13. GLEN AIM, JOHNSON AL. SHERPHERD M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness. A randomized, double blind controlled trial, Psychological Medicine 14: 37-50, 1984.
14. GUY W. The ECDEU Assessment Manual for Psychopharmacology, revised, DHEW Publ. No. (ADM) 76-338, Rockville, MD: National Institute of Mental Health, 1976.
15. HAMILTON M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23: 56-62, 1960
16. KLERMAN GL. DIMASCIO A., WEISSMAN M. PRUSOFF B. PAYKEL E. Treatment of depression with drugs and psychotherapy, American Journal of Psychiatry 131- 186-191, 1974.
17. MARTILA M JÄÄSKELÄINEN J., JÄRVI R., ROMANOV M., MIETTINEN E., SORRI P , AHLFORS P, ZIVKOV M.A. double blind study comparing efficacy and tolerability of Org 3770 and doxepin in patients with major depression, submitted.
18. MINDHAM RHS., HOWLAND O., SHEPHERD M. An evaluation of continuation therapy with triyclic antidepressants in depressive illness, Psychological Medicine 3: 5-17; 1973.
19. MONTGOMERY SA., DUFOUR H., BRION S., GAILLEDREAU J., LACQUEILLE X., FERREY G., MORON P., PARANT-LUCENA N., SINGER L., DANION JM., BEUZEN JN., PIERREDON MA. The prophylatic efficacy of fluoxetine in unipolar depression, British Journal of Psychiatry 53 (suppl, 3): 69-73, 1988.
20. MONTGOMERY SA., DUNBAR G. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. International Clinical Psychopharmacology 8: 189-195, 1993.
21. MONTGOMERY SA, RASMUSSEN JGC, TANGHOJ P. A 24-week study of 20 mg citalopram, 40 mg citalopram and placebo in the prevention of relapse of major depression. International Clinical Psychopharmacology 8: 181-188, 1993
22. MONTGOMERY SA, Prophylasis in recurrent unipolar depression: a new indication for treatment studies, Journal of Psychopharmacology 3: 47-53; 1989.
23. NICKOLSON VJ, RADHAKISHUN F. SITSEN JMA, VAN DELFT AML. Remeron (Org 3770), and "atypical" antidepressant with "typical" efficacy. Abstract No. 109., presented at the 9th World Congress of Psychaitry, Rio de Janeiro, June 6th, 1993.
24. PRIEN RF., KUPFER DJ., MANSKY PA., SMALL JG., TUASON VB, VOSS CB, JOHNSON WE. Drug therapy in the prevention of the prevention of recurrences in unipolar and bipolar affective disorders. Archives of General Psychiatry 41: 1096-1104, 1984.
25. PRIEN RF., KUPFER DJ. Continuation drug therapy for major depressive episodes: How long should it be maintained? The American Journal of Psychiatry 143: 18-23, 1986.
26. PRIEN RF. Long term treatment of affective disorders, In: HY Meltzer (ed.) Psychopharmacology: The Third Generation of Progress, Raven Press, New York, pp. 1051-1058,1 987.
27. RICHOU H, RUIMY P, CHARBAUT J, DELISLE JP., BRUNNER H., PATRIS M., ZIVKOV M. A multicentre, double-blind, clomipramine-controlled efficacy and safety study of Org 3770, submitted, Human Psychopharmacology, in press.
28. ROUILLON F., PHILLIPS R., SERRURIER D. et al. Rechutes de depression unipolaire et efficacite de la maprotiline. L'Encephale 15: 527-534, 1989.
29. SMITH WT., GLAUDIN V., PANAGIDES J., GILVARY E. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Psychopharmacology Bulletin 26: 191-196, 1990.
30. STEIN M.., RICKELS K., WEISSE CC. Mainterance therapy with amitriptyline: a controlled trial The American Journal of Psychiatry 137: 370-371, 1980.
31. VAN MOFFAERT M., DE WILDE D., VEREECKEN A., DIERICK M., EVRARDD JL., WILMOTTE J., MEDLEWIEZ J. Mirtazapine is more effective than trazodone. A controlled study in hospitalised patients with major depression International Clinical Psychopharmacology, in press.
32. WHO MENTAL HEALTH COLLABORATING CENTRES. Pharmacology of depressive disorders: A consensus statement, Journal of Affective Disorders 17: 197-198, 1989.
33. ZIVKOV M., DE JONGH GD. Org 3770 vs amitriptyline: a 6-week randomised double-blind multicentre trial hospitalised depressed patients, Human Psychopharmacology, in press.